416 related articles for article (PubMed ID: 19276450)
1. ABO blood group and the risk of pancreatic cancer.
Wolpin BM; Chan AT; Hartge P; Chanock SJ; Kraft P; Hunter DJ; Giovannucci EL; Fuchs CS
J Natl Cancer Inst; 2009 Mar; 101(6):424-31. PubMed ID: 19276450
[TBL] [Abstract][Full Text] [Related]
2. ABO blood group and risk of coronary heart disease in two prospective cohort studies.
He M; Wolpin B; Rexrode K; Manson JE; Rimm E; Hu FB; Qi L
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2314-20. PubMed ID: 22895671
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium.
Wolpin BM; Kraft P; Gross M; Helzlsouer K; Bueno-de-Mesquita HB; Steplowski E; Stolzenberg-Solomon RZ; Arslan AA; Jacobs EJ; Lacroix A; Petersen G; Zheng W; Albanes D; Allen NE; Amundadottir L; Anderson G; Boutron-Ruault MC; Buring JE; Canzian F; Chanock SJ; Clipp S; Gaziano JM; Giovannucci EL; Hallmans G; Hankinson SE; Hoover RN; Hunter DJ; Hutchinson A; Jacobs K; Kooperberg C; Lynch SM; Mendelsohn JB; Michaud DS; Overvad K; Patel AV; Rajkovic A; Sanchéz MJ; Shu XO; Slimani N; Thomas G; Tobias GS; Trichopoulos D; Vineis P; Virtamo J; Wactawski-Wende J; Yu K; Zeleniuch-Jacquotte A; Hartge P; Fuchs CS
Cancer Res; 2010 Feb; 70(3):1015-23. PubMed ID: 20103627
[TBL] [Abstract][Full Text] [Related]
4. ABO blood group and incidence of skin cancer.
Xie J; Qureshi AA; Li Y; Han J
PLoS One; 2010 Aug; 5(8):e11972. PubMed ID: 20694147
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of ABO blood type and the risk of pulmonary embolism in two large cohort studies.
Wolpin BM; Kabrhel C; Varraso R; Kraft P; Rimm EB; Goldhaber SZ; Camargo CA; Fuchs CS
Thromb Haemost; 2010 Nov; 104(5):962-71. PubMed ID: 20886188
[TBL] [Abstract][Full Text] [Related]
6. ABO blood group and risk of renal cell cancer.
Joh HK; Cho E; Choueiri TK
Cancer Epidemiol; 2012 Dec; 36(6):528-32. PubMed ID: 22841339
[TBL] [Abstract][Full Text] [Related]
7. Dietary fatty acids and pancreatic cancer in the NIH-AARP diet and health study.
Thiébaut AC; Jiao L; Silverman DT; Cross AJ; Thompson FE; Subar AF; Hollenbeck AR; Schatzkin A; Stolzenberg-Solomon RZ
J Natl Cancer Inst; 2009 Jul; 101(14):1001-11. PubMed ID: 19561318
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of periodontal disease and pancreatic cancer in US male health professionals.
Michaud DS; Joshipura K; Giovannucci E; Fuchs CS
J Natl Cancer Inst; 2007 Jan; 99(2):171-5. PubMed ID: 17228001
[TBL] [Abstract][Full Text] [Related]
9. ABO blood type, long-standing diabetes, and the risk of pancreatic cancer.
Egawa N; Lin Y; Tabata T; Kuruma S; Hara S; Kubota K; Kamisawa T
World J Gastroenterol; 2013 Apr; 19(16):2537-42. PubMed ID: 23674856
[TBL] [Abstract][Full Text] [Related]
10. ABO blood group alleles and the risk of pancreatic cancer in a Japanese population.
Nakao M; Matsuo K; Hosono S; Ogata S; Ito H; Watanabe M; Mizuno N; Iida S; Sato S; Yatabe Y; Yamao K; Ueda R; Tajima K; Tanaka H
Cancer Sci; 2011 May; 102(5):1076-80. PubMed ID: 21306478
[TBL] [Abstract][Full Text] [Related]
11. ABO blood group and breast cancer incidence and survival.
Gates MA; Xu M; Chen WY; Kraft P; Hankinson SE; Wolpin BM
Int J Cancer; 2012 May; 130(9):2129-37. PubMed ID: 21633955
[TBL] [Abstract][Full Text] [Related]
12. ABO blood group and risk of colorectal cancer.
Khalili H; Wolpin BM; Huang ES; Giovannucci EL; Kraft P; Fuchs CS; Chan AT
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):1017-20. PubMed ID: 21415359
[TBL] [Abstract][Full Text] [Related]
13. Regular Use of Aspirin or Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs Is Not Associated With Risk of Incident Pancreatic Cancer in Two Large Cohort Studies.
Khalaf N; Yuan C; Hamada T; Cao Y; Babic A; Morales-Oyarvide V; Kraft P; Ng K; Giovannucci E; Ogino S; Stampfer M; Cochrane BB; Manson JE; Clish CB; Chan AT; Fuchs CS; Wolpin BM
Gastroenterology; 2018 Apr; 154(5):1380-1390.e5. PubMed ID: 29229401
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic cancer risk is modulated by inflammatory potential of diet and ABO genotype: a consortia-based evaluation and replication study.
Antwi SO; Bamlet WR; Pedersen KS; Chaffee KG; Risch HA; Shivappa N; Steck SE; Anderson KE; Bracci PM; Polesel J; Serraino D; La Vecchia C; Bosetti C; Li D; Oberg AL; Arslan AA; Albanes D; Duell EJ; Huybrechts I; Amundadottir LT; Hoover R; Mannisto S; Chanock SJ; Zheng W; Shu XO; Stepien M; Canzian F; Bueno-de-Mesquita B; Quirós JR; Zeleniuch-Jacquotte A; Bruinsma F; Milne RL; Giles GG; Hébert JR; Stolzenberg-Solomon RZ; Petersen GM
Carcinogenesis; 2018 Jul; 39(8):1056-1067. PubMed ID: 29800239
[TBL] [Abstract][Full Text] [Related]
15. Statin use and pancreatic cancer risk in two prospective cohort studies.
Hamada T; Khalaf N; Yuan C; Babic A; Morales-Oyarvide V; Qian ZR; Nowak JA; Ng K; Kraft P; Rubinson DA; Stampfer MJ; Giovannucci EL; Fuchs CS; Ogino S; Wolpin BM
J Gastroenterol; 2018 Aug; 53(8):959-966. PubMed ID: 29362938
[TBL] [Abstract][Full Text] [Related]
16. Diabetes, Weight Change, and Pancreatic Cancer Risk.
Yuan C; Babic A; Khalaf N; Nowak JA; Brais LK; Rubinson DA; Ng K; Aguirre AJ; Pandharipande PV; Fuchs CS; Giovannucci EL; Stampfer MJ; Rosenthal MH; Sander C; Kraft P; Wolpin BM
JAMA Oncol; 2020 Oct; 6(10):e202948. PubMed ID: 32789511
[TBL] [Abstract][Full Text] [Related]
17. Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium.
Wolpin BM; Kraft P; Xu M; Steplowski E; Olsson ML; Arslan AA; Bueno-de-Mesquita HB; Gross M; Helzlsouer K; Jacobs EJ; LaCroix A; Petersen G; Stolzenberg-Solomon RZ; Zheng W; Albanes D; Allen NE; Amundadottir L; Austin MA; Boutron-Ruault MC; Buring JE; Canzian F; Chanock SJ; Gaziano JM; Giovannucci EL; Hallmans G; Hankinson SE; Hoover RN; Hunter DJ; Hutchinson A; Jacobs KB; Kooperberg C; Mendelsohn JB; Michaud DS; Overvad K; Patel AV; Sanchéz MJ; Sansbury L; Shu XO; Slimani N; Tobias GS; Trichopoulos D; Vineis P; Visvanathan K; Virtamo J; Wactawski-Wende J; Watters J; Yu K; Zeleniuch-Jacquotte A; Hartge P; Fuchs CS
Cancer Epidemiol Biomarkers Prev; 2010 Dec; 19(12):3140-9. PubMed ID: 20971884
[TBL] [Abstract][Full Text] [Related]
18. ABO Blood Group and Diabetes Mellitus Influence the Risk for Pancreatic Cancer in a Population from China.
Li X; Xu H; Gao P
Med Sci Monit; 2018 Dec; 24():9392-9398. PubMed ID: 30582832
[TBL] [Abstract][Full Text] [Related]
19. The Healthy Eating Index 2005 and risk for pancreatic cancer in the NIH-AARP study.
Arem H; Reedy J; Sampson J; Jiao L; Hollenbeck AR; Risch H; Mayne ST; Stolzenberg-Solomon RZ
J Natl Cancer Inst; 2013 Sep; 105(17):1298-305. PubMed ID: 23949329
[TBL] [Abstract][Full Text] [Related]
20. Associations between ABO blood groups and pancreatic ductal adenocarcinoma: influence on resection status and survival.
El Jellas K; Hoem D; Hagen KG; Kalvenes MB; Aziz S; Steine SJ; Immervoll H; Johansson S; Molven A
Cancer Med; 2017 Jul; 6(7):1531-1540. PubMed ID: 28556564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
